Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698412 | Clinical Oncology | 2015 | 9 Pages |
Abstract
BRCA1/2 mutation status does not preclude treatment with wide local excision and radiotherapy. Given the retrospective studies with inherent flaws and small patient numbers, further large prospective trials are required.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Hallam, S. Govindarajulu, B. Huckett, A. Bahl,